The Patent Finder

Terms ending in 2036

Genentech, Inc.

Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,202,354Therapeutic Compounds and Uses Thereof
In force
 · Medium confidence
Constellation Pharmaceuticals, Inc.In forceMedium confidence
US 10,239,861Therapeutic Compounds and Uses Thereof
In force
 · Medium confidence
Constellation Pharmaceuticals, Inc.In forceMedium confidence
US 10,280,149Therapeutic Compounds and Uses Thereof
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,912,823Methods of Preparing a Poloxamer for Use in Cell Culture Medium
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 10,202,378Therapeutic Compounds and Uses Thereof
In force
 · High confidence
Constellation Pharmaceuticals, Inc.In forceHigh confidence
US 12,098,426Gene Expression Markers and Treatment of Multiple Sclerosis
In force
 · Medium confidence
Genentech, Inc.In forceMedium confidence
US 10,330,683Mutant Smoothened and Methods of Using the Same
In force
 · High confidence
Université Paris CitéIn forceHigh confidence
US 11,236,391Gene Expression Markers and Treatment of Multiple Sclerosis
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 10,077,318Cysteine Engineered Antibodies and Conjugates
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
US 10,179,782Substituted Sulfonamide Compounds
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
101 more term ends in 2036 · Pro
10 of 111 patents shown. Soonest term end first, then patent number.
Pro members see all 111.
Upgrade to Pro
101 of these are in force and held by Genentech, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited